0001567619-20-008036.txt : 20200416 0001567619-20-008036.hdr.sgml : 20200416 20200416161206 ACCESSION NUMBER: 0001567619-20-008036 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200414 FILED AS OF DATE: 20200416 DATE AS OF CHANGE: 20200416 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ALBRECHT DETLEF CENTRAL INDEX KEY: 0001286642 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39041 FILM NUMBER: 20796541 MAIL ADDRESS: STREET 1: SATSUMA PHARMACEUTICALS, INC. STREET 2: 400 OYSTER POINT BOULEVARD, SUITE 221 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Satsuma Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001692830 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 813039831 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 400 OYSTER POINT BOULEVARD STREET 2: SUITE 221 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 64080 BUSINESS PHONE: 415-505-0809 MAIL ADDRESS: STREET 1: 400 OYSTER POINT BOULEVARD STREET 2: SUITE 221 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 64080 4 1 doc1.xml FORM 4 X0306 4 2020-04-14 0 0001692830 Satsuma Pharmaceuticals, Inc. STSA 0001286642 ALBRECHT DETLEF C/O SATSUMA PHARMACEUTICALS, INC. 400 OYSTER POINT BOULEVARD, SUITE 221 SOUTH SAN FRANCISCO CA 94080 0 1 0 0 Chief Medical Officer Common Stock 2020-04-14 4 M 0 800 4.56 A 20812 D Common Stock 2020-04-14 4 S 0 800 20.00 D 20012 D Stock Option (Right to Buy) 4.56 2020-04-14 4 S 0 800 0 D 2029-05-16 Common Stock 800 72468 D Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person. The option vest and become exercisable in successive, equal monthly installments over four years measured from May 15, 2019, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date. /s/ Thomas P. O'Neil as Attorney in Fact for Detlef Albrecht, M.D. 2020-04-16